HHSN26100004 TORFP IV/IV 2013-3 Evaluation of GLG-302, a STAT3 Antagonist in the Prevention of Mammary Cancer

Grant

Date/time Interval

  • September 12, 2014 - September 11, 2017
  • Total Award Amount

  • 395906.00
  • Direct Costs

  • 269593.00
  • Sponsor Award Id

  • HHSN26100004
  • Contributor

  • Grubbs Ph.D., Clinton   Principal Investigator  
  • Juliana, M   Investigator